Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Purification System

By Drug Discovery Trends Editor | August 26, 2010

gilsonGilson, Inc., an industry leader in purification systems for HPLC, SPE and GPC clean-up, introduces a personal bench top purification system. The Gilson PLC 2020 Personal Purification System provides a complete, compact design with interchangeable pump heads for flow rates of 25 mL/min at 4600 psi, 50 mL/min at 2100 psi, and 100 mL/min at 1200 psi. The system is ideally suited for both high pressure reverse phase and normal phase applications with built in selection of up to 5 separate solvents. The system has electronically actuated manual injections of up to 10 mL volumes and variable dual wavelength UV/VIS detection. All fraction collection control and method creation are controlled from an integrated touchscreen display. The intuitive and simple user interface allows even the most novice user to be purifying compounds in minutes.

A scientist from a leading academic in a drug discovery program had this to say about the new PLC 2020 Personal Purification System, “It’s great to see that a company listens and responds to scientists’ concerns. Gilson’s PLC 2020 is a perfect combination of flexibility, small footprint, cost, and ease-of-use. It’s flexible in the fact that you can use it for everything from low pressure flash runs, up to high pressure/high performance chromatography purifications of various scales. You also have the ability to customize the unit to meet the needs of your application.”

Gilson, Inc.


Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE